INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Systematic review / meta-analysis / 2020

Taurine supplementation significantly reduced systolic and diastolic blood pressure, total cholesterol, and triglycerides in randomized controlled trials.

A meta-analysis of 12 randomized controlled trials evaluated the effects of taurine supplementation (0.5 to 6 g/d for 15 days to 6 months), primarily in patients with liver or metabolic dysregulation. Taurine significantly reduced systolic blood pressure (WMD: -4.67 mm Hg; 95% CI, -9.10 to -0.25), diastolic blood pressure (WMD: -2.90 mm Hg; 95% CI, -4.29 to -1.52), total cholesterol (WMD: -10.87 mg/dl; 95% CI, -16.96 to -4.79), and triglycerides (WMD: -13.05 mg/dl; 95% CI, -25.88 to -0.22). It had no significant effect on fasting blood glucose (WMD: 0.06 mg/dl), HDL-C (WMD: 0.90 mg/dl), LDL-C (WMD: -6.17 mg/dl), body mass index (WMD: -0.46 kg/m2), or body weight (WMD: -0.47 kg).

Study type
Systematic review and meta-analysis of randomized controlled trials
Who was studied
Patients mostly with liver or metabolic dysregulation (12 studies)
What was measured
Blood pressure, lipid profile, fasting blood glucose, and anthropometric measures

THE PAPER

The effects of taurine supplementation on obesity, blood pressure and lipid profile: A meta-analysis of randomized controlled trials.

Guan L, Miao P. Eur J Pharmacol, 2020.

PubMed 32871172 ↗DOI 10.1016/j.ejphar.2020.173533 ↗

Heart & arteriesBlood pressureNutrients & adequacy

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.